- Tytuł:
- Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet 4-10 November 2023 402(10413):1648-1659
Czasopismo naukowe